Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics.
about
Proteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha.Comparative pathogenesis and systems biology for biodefense virus vaccine development.Interference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infectionA systems biology starter kit for arenaviruses.The search for animal models for Lassa fever vaccine developmentAn attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses.Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection.Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.
P2860
Q33656417-24F5213F-4AE8-4BFC-8ABA-F4024D430C4AQ33959989-A6E0565B-8CAF-456E-A5C9-3F69A3769BB9Q34347141-24E2B5D7-31FE-40EA-A636-7B846C971D1EQ34647510-850D1280-06A3-48BA-9D35-F9AE08441758Q36588064-26F83593-85A4-4327-9E2A-9CB50E0A62BFQ36698306-F301D933-8DC8-40B7-B1D9-8B38085BA20FQ37394607-D949D1D5-BB8E-4680-8C0F-D731D52EE84EQ37884343-B7D7A528-0C83-4D62-9477-739FF0B34677Q38615950-7587B4A8-22AC-4D60-AC73-BEB564BE7C0FQ40285838-8493EABF-0CE0-4AB9-9CF5-D6A518608DA2
P2860
Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Attenuated and lethal variants ...... target for novel therapeutics.
@ast
Attenuated and lethal variants ...... target for novel therapeutics.
@en
type
label
Attenuated and lethal variants ...... target for novel therapeutics.
@ast
Attenuated and lethal variants ...... target for novel therapeutics.
@en
prefLabel
Attenuated and lethal variants ...... target for novel therapeutics.
@ast
Attenuated and lethal variants ...... target for novel therapeutics.
@en
P2093
P2860
P356
P1433
P1476
Attenuated and lethal variants ...... target for novel therapeutics.
@en
P2093
Bruce A Luxon
David G Gorenstein
Gavin C Bowick
Judith F Aronson
Lihong Zhang
Norbert K Herzog
Robert E Shope
Susan M Fennewald
Xianbin Yang
P2860
P304
P356
10.1089/VIM.2009.0034
P577
2009-12-01T00:00:00Z